Physician profile
Stephen A Spencer
NPI 1104814235
$1,937.75
in general payments reported to CMS, 2019-2025
17 companies · $310 in 2025
The $310 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $35.90 · 2021: $11.72 · 2022: $163 · 2023: $443 · 2024: $391 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $676.20 | 2019-2025 | Rinvoq, Skyrizi |
| Novartis Pharmaceuticals Corporation | $235.64 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $228.16 | 2023-2025 | Ilumya |
| Lilly USA, LLC | $159.84 | 2022-2025 | Taltz, Ebglyss, Zepbound |
| Galderma Laboratories, L.P. | $126.46 | 2019-2022 | |
| Janssen Biotech, INC. | $98.65 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $78.93 | 2022-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $70.99 | 2024-2025 | Dupixent |
| Sensus Healthcare, INC. | $67.22 | 2019 | |
| Leo Pharma INC. | $47.36 | 2022-2024 | Adbry |
| Genzyme Corporation | $35.30 | 2024 | |
| Allergan, INC. | $31.76 | 2019 | |
| Dermira, INC. | $18.27 | 2020 | |
| Amgen INC. | $17.63 | 2020 | |
| Dermavant Sciences, INC. | $16.82 | 2023 | Vtama |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.80 | 2023 | |
| Strata Skin Sciences, INC. | $11.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.